Krystal Biotech Inc (NASDAQ: KRYS) is a biotechnology company focused on developing and commercializing gene therapy products. The filing excerpts provided from the 10-K filed 2026-02-17 (accession 000171127926000016) do not contain sufficient business, financial, or operational detail to construct a fully grounded canonical description meeting the required specificity standards. No revenue figures, product names, customer data, competitive positioning, founding history, or leadership information are present in the supplied excerpts. To avoid unsupported claims, a complete description cannot be generated from this source material alone.

Source: SEC 10-K, filed 2026-02-17

Industry: Biological Products, (No Diagnostic Substances) Peers: Allogene Therapeutics Inc Arcus Biosciences Inc Immunitybio Inc IVERIC bio, Inc. Lyell Immunopharma Inc Revolution Medicines Inc Recursion Pharmaceuticals Inc Twist Bioscience Corp Verve Therapeutics, Inc.